logo
episode-header-image
Apr 2023
39m 12s

Encore: Diet Wars | Dieting 3.0 | 5

Wondery
About this episode
First there was Weight Watchers, then there was Noom, and now there’s…Wegovy? Bloomberg health reporter Emma Court helps us understand the evolution of dieting programs and where they’re going next. Later, Matthew Schnier of New York Magazine and The Cut walks us through his article “Life After Food,” which explores the latest wave of weight loss drugs, like ... Show More
Up next
Apr 2023
Best of Business Wars Daily | Chat Chat Revolution | 6
The AI revolution is here and the tech behemoths are building and releasing their own chatbots. To talk about their victories and blunders, we're joined by Vox journalist Shirin Ghaffary and comedian and podcast host Jolenta Greenberg.Binge all episodes early and ad-free with Won ... Show More
32m 59s
Apr 2023
Encore: Tesla vs Detroit | Accelerate Faster | 1
While the U.S. government pushed automakers to make low-emission vehicles in the 1990s, consumers loved their gas-guzzling trucks and SUVs. But in 2003, Elon Musk's Tesla Motors arrives with environmentally friendly, high-performance cars that people actually want.Motor City smir ... Show More
38m 58s
Apr 2023
Encore: Tesla vs Detroit | Survival Mode | 2
In 2010, Tesla Motors has already experienced tremendous highs and devastating lows. Elon Musk is a polarizing figure whose goal is to change the way the traditional auto industry works. It’s been a struggle, but Detroit is finally bowing to the Tesla vision, moving electric vehi ... Show More
35m 43s
Recommended Episodes
Dec 2024
A checkup on weight-loss drugs
What started as a story about Hollywood waistlines has become a global phenomenon. Weight loss drugs are becoming more and more mainstream a few years after making their dramatic debut. On this weekend episode of Reuters World News, our health reporters weigh in on the impact of ... Show More
20m 17s
Apr 2023
🏋️ “A slimdown in a syringe” — Weight Watchers’ Ozempic win. Rihanna’s perfume power. Tax Day’s big battle.
The latest fad diet isn’t a diet, it’s a shot — Ozempic is being called a miracle weight loss drug, and it’s disrupting Weight Watchers. LVMH is proud of their pricey perfume, and they are selling more than ever thanks to their Rihanna-aided storytelling. And H&R Block vs. TurboT ... Show More
22m 14s
Dec 2024
068 | The weight is over: How GLP-1 treatments are reshaping pharma and beyond
Weight-loss drugs have become a golden formula for pharma growth. In this episode we speak to Sector Advisor Maria Latorre and Senior Economist Michaela Grimm about how GLP-1 treatments like Ozempic and Wegovy are reshaping the industry, and the risks that lie ahead. SHOWNOTES: • ... Show More
11m 16s
Feb 2024
The Big Business Behind Weight Loss Drugs
It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sa ... Show More
33m 54s
Jul 2023
How Drugs Like Ozempic Are Changing What We Think About Weight Loss
You may have heard about Ozempic, Wegovy and Mounjaro. It’s tough to miss the online chatter, the ads on TV and all the news coverage. They are part of a class of drugs originally designed to treat diabetes, and all three have been shown to help people lose significant amounts of ... Show More
28m 5s
Dec 2024
How Ozempic Transformed the Way We Look at Obesity
Ozempic, Wegovy, and Mounjaro, are being called “miracle drugs” with users boasting about their fast results. Dr. Sanjay Gupta takes a deep dive into how they disrupted the entire weight loss industry and changed the conversation about obesity.  Learn more about your ad choices. ... Show More
23m 47s